Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析

◆英語タイトル:Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH659FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:99
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥43,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Johnson & Johnson (JNJ) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Johnson & Johnson (J&J) researches, develops, manufactures, and sells pharmaceutical products, medical devices and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious, cardiovascular and metabolic diseases; consumer products in oral care, baby care, beauty, over-the-counter (OTC) pharmaceutical, women’s health and wound care categories; and medical devices for use in the cardiovascular, orthopaedic, general surgery and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, health care professionals and hospitals; and offers consumer products through retail outlets and distributors. The company offers its products in the US; Europe; Asia-Pacific and Africa; and Western Hemisphere (excluding the US). J&J is headquartered in New Brunswick, New Jersey, the US.

Johnson & Johnson Key Recent Developments

Mar 10,2021: Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
Mar 05,2021: Australian court dismisses J&J’s appeal in pelvic mesh class action
Mar 01,2021: GRAM Applauds FDA Emergency Use Authorization for Johnson & Johnson COVID-19 Vaccine
Feb 03,2021: REVEAL Lite 2 Risk Calculator offers simplified model to assess one-year mortality risk status in patients with Pulmonary Arterial Hypertension
Feb 02,2021: Janssen to highlight robust solid tumor portfolio and pipeline at 2021 ASCO GU

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Johnson & Johnson – Key Facts
Johnson & Johnson – Key Employees
Johnson & Johnson – Key Employee Biographies
Johnson & Johnson – Major Products and Services
Johnson & Johnson – History
Johnson & Johnson – Company Statement
Johnson & Johnson – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Johnson & Johnson – Business Description
Business Segment: Consumer
Overview
Performance
Key Stats
Business Segment: Medical Devices
Overview
Performance
Key Stats
Business Segment: Pharmaceutical
Overview
Performance
Key Stats
Geographical Segment: Asia-Pacific, Africa
Performance
Geographical Segment: Europe
Performance
Geographical Segment: The US
Performance
Geographical Segment: Western Hemisphere excluding U.S.
Performance
R&D Overview
Johnson & Johnson – Corporate Strategy
Johnson & Johnson – SWOT Analysis
SWOT Analysis – Overview
Johnson & Johnson – Strengths
Johnson & Johnson – Weaknesses
Johnson & Johnson – Opportunities
Johnson & Johnson – Threats
Johnson & Johnson – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Johnson & Johnson, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 10, 2021: Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
Mar 05, 2021: Australian court dismisses J&J’s appeal in pelvic mesh class action
Mar 01, 2021: GRAM Applauds FDA Emergency Use Authorization for Johnson & Johnson COVID-19 Vaccine
Feb 03, 2021: REVEAL Lite 2 Risk Calculator offers simplified model to assess one-year mortality risk status in patients with Pulmonary Arterial Hypertension
Feb 02, 2021: Janssen to highlight robust solid tumor portfolio and pipeline at 2021 ASCO GU
Jan 26, 2021: Johnson & Johnson reports 2020 fourth-quarter and full year results
Jan 14, 2021: Johnson & Johnson statement on political contributions
Jan 11, 2021: South Carolina Life Sciences conference to feature BIO global executive among national speakers at SCBIO 2021 Feb. 16-17
Dec 15, 2020: Veracyte announces expansion of collaboration with the Lung Cancer Initiative at Johnson & Johnson
Dec 03, 2020: Johnson & Johnson names Dr. Nadja West, retired United States Army lieutenant general and former United States Army Surgeon General to its board of directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Johnson & Johnson, Key Facts
Johnson & Johnson, Key Employees
Johnson & Johnson, Key Employee Biographies
Johnson & Johnson, Major Products and Services
Johnson & Johnson, History
Johnson & Johnson, Subsidiaries
Johnson & Johnson, Key Competitors
Johnson & Johnson, Ratios based on current share price
Johnson & Johnson, Annual Ratios
Johnson & Johnson, Annual Ratios (Cont...1)
Johnson & Johnson, Annual Ratios (Cont...2)
Johnson & Johnson, Interim Ratios
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Johnson & Johnson, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sernova Corp (SVA):医療機器:M&Aディール及び事業提携情報
    Summary Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like …
  • CMS Energy Corporation:発電所・企業SWOT分析
    CMS Energy Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • Transnet SOC Ltd:企業の戦略的SWOT分析
    Transnet SOC Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Marks and Spencer Group plc:企業の戦略・SWOT・財務分析
    Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report Summary Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Bauhaus International (Holdings) Limited (483):企業の財務・戦略的SWOT分析
    Bauhaus International (Holdings) Limited (483) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • American CryoStem Corp (CRYO):企業の財務・戦略的SWOT分析
    Summary American CryoStem Corp (American CryoStem), formerly Advanced Wound Technologies-MidAtlantic LLC is a manufacturer, developer, and marketer of life-enhancing and stem cell technologies. The company offers products such as adipose derived stem cells, tissue collection and transportation produ …
  • Asian Citrus Holdings Ltd (73):企業の財務・戦略的SWOT分析
    Asian Citrus Holdings Ltd (73) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Shenzhen Topray Solar Co Ltd (002218):企業の財務・戦略的SWOT分析
    Shenzhen Topray Solar Co Ltd (002218) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Octapharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Octapharma AG (Octapharma) is a human protein manufacturer that focuses on developing and producing human proteins from human plasma and cell lines. The company treats patients worldwide with products across immunotherapy (immune disorders), haematology (coagulation disorders), and critical …
  • Biomatrica Inc-医療機器分野:企業M&A・提携分析
    Summary Biomatrica Inc (Biomatrica) is a biological stabilization products developer that offers healthcare technology products. The company offers assay design and use; omics sample collection, and transport and storage chemistry products. Its transport and storage chemistry products comprise custo …
  • TWi Pharmaceuticals Inc (4180)-製薬・医療分野:企業M&A・提携分析
    Summary TWi Pharmaceuticals Inc (TWi), formerly Anchen Pharmaceuticals (Taiwan) Inc is a manufacturer of high barrier generics drugs. The company’s products include donepezil hydrochloride tablets, hydroquinone cream, hydroquinone time release cream, megestrol acetate oral suspension and nifedipine …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • DiaCarta Inc:企業の製品パイプライン分析2018
    Summary DiaCarta Inc (DiaCarta) is a developer of molecular diagnostics products for cancer and infectious diseases. The company offers genomic testing for biomarkers and also provides clinical sample testing services in their CLIA-certified lab. It offers products such as gene mutation detection ki …
  • Nanolek-製薬・医療分野:企業M&A・提携分析
    Summary Nanolek specializes in the production of import-substituting and novel pharmaceuticals. The company’s product portfolio includes vaccines; drugs for treatment of leukemias, brain cancer, breast cancer, stomach and ovarian cancer, colorectal cancer, HIV infection and other diseases. Nanolek a …
  • Evoqua Water Technologies Corp (AQUA):電力:M&Aディール及び事業提携情報
    Summary Evoqua Water Technologies Corp (Evoqua) is a clean technology company that provides wastewater treatment systems and solutions. It offers various products such as activated carbons, systems for filtration, aeration and mixing, biological treatment, anaerobic digestion processes; and oil wate …
  • GamaMabs Pharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary GamaMabs Pharma SA (GamaMabs) is a clinical-stage immuno-oncology company that develops optimized therapeutic antibodies for the treatment of cancer. The company’s lead product candidate GM102, is an anti-AMHR2, Emabling engineered humanized mAb product targeting the receptor of anti-Mulleri …
  • Concept Packaging Group:企業の戦略・SWOT・財務分析
    Concept Packaging Group - Strategy, SWOT and Corporate Finance Report Summary Concept Packaging Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Hilton Grand Vacations Inc (HGV):企業の財務・戦略的SWOT分析
    Hilton Grand Vacations Inc (HGV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • SMART Global Holdings, Inc. (SGH):企業の財務・戦略的SWOT分析
    SMART Global Holdings, Inc. (SGH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Obsidian Energy Ltd (OBE):石油・ガス:M&Aディール及び事業提携情報
    Summary Obsidian Energy Ltd (Obsidian) is formerly known as Penn West Petroleum Ltd. It is a conventional oil and natural gas production and development company in Canada with a well-balanced portfolio of high-quality assets. It develops and explores oil and gas properties and related production inf …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆